António Ferreira

Dr. António Ferreira

orcid

Research Focus & Metrics

Academic Career Length

19Years (2008-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
23 July 2009 in EP Europace
Verified
Journal Article
Open access
PDF file
JAJoão Abecasis
João Abecasis
RDRaquel Dourado
Raquel Dourado
AFAntónio Ferreira
António Ferreira
CSCarla Saraiva
Carla Saraiva
DCDiogo Cavaco
Diogo Cavaco
ASAniceto Silva
Aniceto Silva
Catheter ablation (CA) of atrial fibrillation (AF) might be a definitive curative therapy for selected groups of patients (pts). However, current ablation protocols are not standardized and predictors of CA success and sinus rhythm maintenance are not clearly defined. To evaluate whether left atrium (LA) volume quantification provided by multi-detector computed tomography (MDCT) might predict the success of pulmonary vein (PV) isolation procedure. We evaluated 99 pts, 66 male, mean age 54.4 ± 10.1 years, referred for CA because of drug resistant AF. All pts were submitted to 64-slice MDCT scan for electroanatomic mapping integration, pulmonary veins anatomy delineation, LA thrombi exclusion, and LA volume estimation. Complete isolation of all the PVs was always performed with eventual cavo-tricuspid isthmus ablation. For a mean follow-up period (Fup) of 16.7 ± 6.6 months, clinical success was assessed after a 3-month blanking period. Anti-arrhythmic drug therapy was discontinued or modified at the clinician's criteria. At the end of the Fup, 29 pts suspended anti-arrhythmic drug therapy and 26% were of oral anticoagulation. Univariate analysis showed that the probability of AF relapse after CA was higher in pts with non-paroxysmal forms of AF. The probability of relapse was significantly higher in pts with LA volumes greater than 100 mL when assessed by MDCT. We found that the LA volume of 145 mL was a good cut-off value for AF recurrence prediction. Patients with LA volumes greater than 145 mL had significantly higher recurrence rates of arrhythmia, even when adjusted for the effect of age, gender, body mass index, hypertension, and type of AF. Left atrium volume estimated by MDCT may be useful to identify pts in whom successful AF ablation can be achieved with simpler ablation procedures, restricted to PV isolation.

1 January 2023 in Radiology
Verified
Journal Article
Closed access
SFStefano Figliozzi
Stefano Figliozzi
GGGeorgios Georgiopoulos
Georgios Georgiopoulos
PLPedro M. Lopes
Pedro M. Lopes
KBKlemens B. Bauer
Klemens B. Bauer
SMSara Moura-Ferreira
Sara Moura-Ferreira
PMPier-Giorgio Masci
Pier-Giorgio Masci
In mitral valve prolapse, myocardial fibrosis at cardiac MRI was associated with an increased risk of unexplained syncope, sustained ventricular tachycardia, or sudden cardiac death. Background Patients with mitral valve prolapse (MVP) may develop adverse outcomes even in the absence of mitral regurgitation or left ventricular (LV) dysfunction. Purpose To investigate the progno...

1 January 2019 in Journal of Cardiovascular Magnetic Resonance
Verified
Journal Article
Open access
PDF file
PFPedro Freitas
Pedro Freitas
AFAntónio Ferreira
António Ferreira
EAEdmundo Arteaga-Fernández
Edmundo Arteaga-Fernández
MAMurrilo de Oliveira Antunes
Murrilo de Oliveira Antunes
JMJoão Mesquita
João Mesquita
CRCarlos Eduardo Rochitte
Carlos Eduardo Rochitte
Identifying the patients with hypertrophic cardiomyopathy (HCM) in whom the risk of sudden cardiac death (SCD) justifies the implantation of a cardioverter-defibrillator (ICD) in primary prevention remains challenging. Different risk stratification and criteria are used by the European and American guidelines in this setting. We sought to evaluate the role of cardiovascular magnetic resonance (CMR) late gadolinium enhancement (LGE) in improving these risk stratification strategies. We conducted a multicentric retrospective analysis of HCM patients who underwent CMR for diagnostic confirmation and/or risk stratification. Eligibility for ICD was assessed according to the HCM Risk-SCD score and the American College of Cardiology Foundation/American Heart Association (ACCF/AHA) algorithm. The amount of LGE was quantified (LGE%) and categorized as 0%, 0.1–10%, 10.1–19.9% and ≥ 20%. The primary endpoint was a composite of SCD, aborted SCD, sustained ventricular tachycardia (VT), or appropriate ICD discharge. A total of 493 patients were available for analysis (58% male, median age 46 years). LGE was present in 79% of patients, with a median LGE% of 2.9% (IQR 0.4–8.4%). The concordance between risk assessment by the HCM Risk-SCD, ACCF/AHA and LGE was relatively weak. During a median follow-up of 3.4 years (IQR 1.5–6.8 years), 23 patients experienced an event (12 SCDs, 6 appropriate ICD discharges and 5 sustained VTs). The amount of LGE was the only independent predictor of outcome (adjusted HR: 1.08; 95% CI: 1.04–1.12; p < 0.001) after adjustment for the HCM Risk-SCD and ACCF/AHA criteria. The amount of LGE showed greater discriminative power (C-statistic 0.84; 95% CI: 0.76–0.91) than the ACCF/AHA (C-statistic 0.61; 95% CI: 0.49–0.72; p for comparison < 0.001) and the HCM Risk-SCD (C-statistic 0.68; 95% CI: 0.59–0.78; p for comparison = 0.006). LGE was able to increase the discriminative power of the ACCF/AHA and HCM Risk-SCD criteria, with net reclassification improvements of 0.36 (p = 0.021) and 0.43 (p = 0.011), respectively. The amount of LGE seems to outperform the HCM Risk-SCD score and the ACCF/AHA algorithm in the identification of HCM patients at increased risk of SCD and reclassifies a relevant proportion of patients.

1 April 2015 in International Journal of Cardiology
Verified
Journal Article
Closed access
FCFrancisco Costa
Francisco Costa
AFAntónio Ferreira
António Ferreira
SOSílvia Oliveira
Sílvia Oliveira
PSPedro Galvão Santos
Pedro Galvão Santos
ADAnai Durazzo
Anai Durazzo
PAPedro Adragão
Pedro Adragão

28 May 2008 in EP Europace
Verified
Journal Article
Open access
PDF file
AFAntónio Ferreira
António Ferreira
PAPedro Adragão
Pedro Adragão
DCDiogo M. Cavaco
Diogo M. Cavaco
RCRui Candeias
Rui Candeias
FMFrancisco B. Morgado
Francisco B. Morgado
JSJosé A. Silva
José A. Silva
To assess the clinical benefit of cardiac resynchronization therapy (CRT) in patients with atrial fibrillation (AF) compared with patients in sinus rhythm (SR), and to evaluate the impact of atrioventricular junction (AVJ) ablation on the outcome of AF patients undergoing CRT. We conducted a retrospective analysis of 131 consecutive heart failure (HF) patients who underwent CRT implantation. Three groups were considered: SR ( n = 78), AF with AVJ ablation ( n = 26), and AF without AVJ ablation ( n = 27). Patients were evaluated for the occurrence of cardiac death, hospitalization for HF, and responsiveness to CRT (survival with improvement of ≥1 New York Heart Association class at 6 months). The three groups showed a significant improvement in functional class. However, the proportion of responders was significantly lower in AF patients without AVJ ablation (52 vs. 79% in SR and 85% in AF with AVJ ablation, P < 0.008). Atrial fibrillation without AVJ ablation was also independently associated with mortality (HR 5.22, 95% CI: 1.60–17.01, P = 0.006) and hospitalization for HF during the first 12 months (HR 6.23, 95% CI: 2.09–18.54, P = 0.001). The outcomes of AF with AVJ ablation patients were similar to the outcomes of patients in SR. Sinus rhythm and AF patients display similar survival and clinical improvement after CRT implantation, provided that AVJ ablation is performed in the latter.

1 May 2013 in The International Journal of Cardiovascular Imaging
Verified
Journal Article
Closed access
PDF file
PGPedro de Araújo Gonçalves
Pedro de Araújo Gonçalves
HGHector M. Garcia-Garcia
Hector M. Garcia-Garcia
HDHélder Alexandre Correia Dores
Hélder Alexandre Correia Dores
MCMaria Salomé Carvalho
Maria Salomé Carvalho
PSPedro Jerónimo Sousa
Pedro Jerónimo Sousa
MMMiguel Mendes
Miguel Mendes